Premium
One decade of improving palliative care of metastatic renal cell carcinoma by antiangiogenic therapies: Time to move toward RCC cure
Author(s) -
Kroeger Nils,
Zimmermann Uwe,
Burchardt Martin
Publication year - 2014
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.29189
Subject(s) - temsirolimus , medicine , sunitinib , pazopanib , axitinib , renal cell carcinoma , sorafenib , nivolumab , everolimus , oncology , immunotherapy , lenvatinib , mtorc1 , cancer , cancer research , pi3k/akt/mtor pathway , discovery and development of mtor inhibitors , biology , apoptosis , biochemistry , hepatocellular carcinoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom